US Education Department Opens Racial Discrimination Probes into Five Medical Schools

Federal Investigations Target Five Medical Schools' Admissions Practices

The U.S. Department of Education's Office for Civil Rights has opened formal investigations into five medical schools for alleged racial discrimination in their admissions processes. The probes, announced on July 23, center on whether the institutions violated Title VI of the Civil Rights Act of 1964, which bars race-based discrimination in programs that receive federal funding. The schools include Dartmouth College's Geisel School of Medicine and Western University of Health Sciences; the Department did not immediately release a full list of the other three schools under scrutiny.

The investigations are being conducted jointly with the Department of Health and Human Services' Office for Civil Rights and the Department of Justice's Civil Rights Division. They are the latest move in a broader Trump administration campaign to eliminate what it calls “illegal” diversity, equity, and inclusion preferences in higher education. Since August 2025, two executive orders have driven more than 300 colleges and universities to dismantle DEI offices, remove diversity statements from hiring, and shift to merit-based scholarship programs. The Department also issued a Dear Colleague letter warning all federally funded educational institutions to stop using race preferences.

The OCR will now examine admissions data and policies at the targeted schools. If violations are found, the schools could face corrective action, including the potential loss of federal financial assistance. The administration has framed the effort as restoring meritocracy and ensuring that applicants are judged on achievement rather than skin color.

What the Investigations Mean for Medical Schools and the Future of Race-Conscious Admissions

The Schools Under Investigation

Dartmouth's medical school and Western University of Health Sciences are the only institutions publicly confirmed. Both are respected medical programs that receive significant federal research and student-aid dollars. Little is known about the specific allegations beyond OCR's statement that they involve racial discrimination in admissions. The investigations come as the administration seeks to make examples of institutions it believes are still employing race-conscious selection, despite the Supreme Court's 2023 ruling against affirmative action in undergraduate admissions.

The Legal and Financial Stakes

Title VI violations carry a heavy potential sanction: withdrawal of federal funds. For medical schools, that could affect research grants, Medicare payments for clinical training, and student loan programs—collectively worth tens of millions of dollars. The joint involvement of HHS and DOJ signals that this is not a routine civil-rights review but a coordinated enforcement priority. Schools found to be in violation would face intense pressure to overhaul their admissions systems, and the reputational damage could deter applicants and donors.

The Broader DEI Crackdown

The investigations are part of a systematic rollback of DEI infrastructure. Earlier actions targeted the Ph.D. Project, a program that restricted eligibility by race, and pressured major universities like Harvard, Stanford, and the University of Michigan to reshape their diversity efforts. The Dear Colleague letter and the threat of further OCR probes have already led many institutions to scrub their websites, rename DEI posts, and reorient scholarship criteria. The medical school probes signal that graduate and professional programs are now firmly in the crosshairs.

Implications for Medical Education

A shift away from race-conscious admissions could alter the demographic makeup of future physician cohorts, especially if the investigations result in a precedent that discourages even holistic consideration of race as one factor among many. Medical associations have warned that a less diverse physician workforce may worsen health disparities. However, the administration argues that merit-based admissions will ultimately serve all patients by selecting the most capable students, regardless of background. The actual impact will depend on how many schools change their practices preemptively and how courts interpret Title VI in the context of professional education.

Action Steps for Medical Schools and Higher Education Institutions

• Medical schools receiving federal funds should immediately review their admissions policies against the Dear Colleague letter and recent enforcement patterns. Any use of racial classifications or quotas—even indirectly—must be verifiably compatible with Title VI as currently interpreted by OCR.
• Schools named in the investigation need to prepare for document requests and interviews; engage legal counsel experienced in Title VI matters; and communicate transparently with faculty, students, and accreditors about the process and possible outcomes.
• Other medical and health-professions schools should anticipate that OCR may expand its inquiry to additional institutions, especially those with public commitments to diversity or race-conscious admissions. A proactive audit of admissions data and recruiting practices is warranted.
• University leadership should coordinate with their general counsel and government affairs teams to track the investigation's progress and any resulting policy guidance, as the joint HHS-DOJ involvement suggests potential cross-agency consequences for health-related programs.
• Prospective medical students should be aware that admissions criteria at targeted and at-risk schools may change mid-cycle; following university statements and consulting pre-health advisors can help manage expectations.